Harvest SSE STAR Biology and Medicine ETF(588700.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Harvest SSE STAR Biology and Medicine ETF
588700.SH
News
View More

2026 China FIC Innovation and Collaboration Summit at J.P. Morgan Healthcare Conference in San Francisco showcased Chinese pharmaceutical company achievements.

On January 16, 2026, during the J.P. Morgan Healthcare Conference in San Francisco, the 2026 China FIC Innovation & Collaboration Summit took place. The event, hosted by the ZFIC Alliance, convened key Chinese figures in the US city.

Unusual Whales·
Unusual Whales·

JPM26: Dealmaking optimism at JPM 2026 despite absence of mega-M&As

The J.P. Morgan Healthcare Conference 2026 highlighted a shift in biopharmaceutical deal-making, focusing on internal pipeline prioritization and licensing agreements rather than large M&As. Despite the absence of mega-deals, optimism remains due to a 59.3% increase in M&A deal value in Q4 2025 and a 157% rise in IPO volume. Notable licensing agreements were announced, including AbbVie's $5.6bn deal with RemeGen and Novartis's agreements totaling over $1.6bn. Industry experts emphasized the need for US investment in R&D to maintain market dominance against China, while demand for innovative drug development continues to grow.

Pharmaceutical Technology·
US
ABBV
-0.31%
SH
688331
+2.24%
HK
09995
+3.77%
Pharmaceutical Technology·
US
ABBV
-0.31%
SH
688331
+2.24%
HK
09995
+3.77%

The Hang Seng Index failed to break through 27,000 for the fourth time, falling by 78 points. Pop Mart dropped by 6%, while AI chip stocks performed well. Experts are concerned that the upward trend may have ended｜Hong Kong stock market closing

The Hang Seng Index closed at 26,844 points on Friday, down 78 points, failing to break through 27,000 points for four consecutive days. Market turnover fell to HKD 255 billion, with a net inflow of HKD 94 million from the north. Despite strong performance from AI chip stocks, with SMIC and Hua Hong Semiconductor rising 2% and 7% respectively, Ctrip saw a decline of 21.8%, becoming the worst-performing blue-chip stock of the week. ALI HEALTH, on the other hand, rose 17.9%, making it the best blue-chip stock. Overall, the Hang Seng Index still rose 613 points for the week

Stheadline·
HK
00241
-5.16%
SH
688347
+6.87%
HK
01347
+7.39%
Stheadline·
HK
00241
-5.16%
SH
688347
+6.87%
HK
01347
+7.39%

Chinese scientists print beating heart-like organs

Chinese scientists at Tsinghua University Research Institute in Shenzhen have successfully printed a "tiny heart" that can beat rhythmically. The project is led by Professor Xu Tao, and in the next three to five years, the team plans to achieve 3D printing of simple organs such as islets and bladders, and provide 3D printed "mini livers" for early-stage liver failure patients for localized repair

Wallstreetcn·
Wallstreetcn·

Hong Kong stock market intraday | The Hang Seng Index fell 0.54% during the session, the semiconductor sector surged in the afternoon, and MINIMAX continued to soar over 15%

The main indices of the Hong Kong stock market experienced slight adjustments during the trading session, with the Hang Seng Index, Hang Seng Tech Index, and the China Enterprises Index all retreating, reflecting a strong wait-and-see sentiment in the market. The performance of major sectors was mixed, with noticeable divergence in retail, internet content, and information sectors, while some leading stocks in technology and life sciences were active. Alibaba rose by 0.55%, attracting significant attention from investors; Tencent Holdings and WuXi AppTec fell by 1.13% and 1.85%, respectively. On the macro front, the market is focused on important economic data, with funds primarily engaged in structural rotation amid a cautious atmosphere

Market Heartbeat·
HK
02269
-0.60%
HK
00981
+2.39%
Market Heartbeat·
HK
02269
-0.60%
HK
00981
+2.39%
© 2026 Longbridge｜Disclaimer